NOVERA RETATRUTIDE: A PROMISING NEW HOPE FOR WEIGHT MANAGEMENT?

Recent clinical information suggests that Novera Retatrutide, a dual-action medication from Novo Nordisk, could provide a meaningful step in weight control. Beyond many existing drugs, Retatrutide affects both glucagon-like peptide-1 (GLP-1) and the GIP hormone, potentially leading to greater red